Work

Combination of Anti-CD123 and Anti-CD19 Chimeric Antigen Receptor T Cells for the Treatment and Prevention of Antigen-Loss Relapses Occurring after CD19-Targeted Immunotherapies

Year: 2015

Type: article

Source: Blood

DOI: 10.1182/blood.v126.23.2523.2523

Authors: Marco Ruella, David M. Barrett, Saad S Kenderian, Olga Shestova, Ted J. Hofmann, John Scholler, Simon F. Lacey, J. Joseph Melenhorst, Farzana Nazimuddin, Jessica Perazzelli, David A Christian, Christopher A Hunter, David L Porter, Carl H. June, Stephan A. Grupp, Saar I Gill

Institutions: University of Pennsylvania, Children's Hospital of Philadelphia, Mayo Clinic, Abramson Cancer Center

Language: English

Topic: CAR-T cell therapy research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2980310532

FWCI: 1.043

Cites:

Cited by: 10

Related to: 10